CDK6 is a novel predictive and prognosis biomarker correlated with immune infiltrates in multiple human neoplasms, including small cell lung carcinoma
Guosheng Li(Guangxi Medical University), Feng Chen(Guangxi Medical University), Jun-Xi Peng(Guangxi Medical University), Jing-Xiao Li(Guangxi Medical University), Jia Tian(East China University of Science and Technology), Neng-Yong Zeng(Beibu Gulf University), Meihua Jin(Guilin Medical University), Jun Liu(Sichuan University), Gang Chen(Zhuhai People's Hospital), Dongming Li(Dalian University), Lin Yang(Wuhan University of Technology), Yu-Xing Tang(Alibaba Group (China)), Jinhua Zheng(Xiangtan University), Zhi-Guang Huang(Guangxi Medical University), Yue Feng(Hangzhou Hospital of Traditional Chinese Medicine), Yu-Lu Tang(Guangxi Medical University), Hua‐Fu Zhou(Guangxi Medical University)
Cited by 6
Related Papers
Targeting Wnt-driven cancer through the inhibition of Porcupine by LGK974
|Proceedings of the National Academy of Sciences|2013|833
Nuclear Receptor-Dependent Bile Acid Signaling Is Required for Normal Liver Regeneration
|Science|2006|635
Complete Surgical Excision Is Essential for the Management of Patients With Breast Implant–Associated Anaplastic Large-Cell Lymphoma
|Journal of Clinical Oncology|2015|418
Association of Cerebral Deficits With Clinical Symptoms in Antipsychotic-Naive First-Episode Schizophrenia: An Optimized Voxel-Based Morphometry and Resting State Functional Connectivity Study
|American Journal of Psychiatry|2008|257
Fabrication and Electrochemical Treatment Application of A Novel Lead Dioxide Anode with Superhydrophobic Surfaces, High Oxygen Evolution Potential, and Oxidation Capability
|Environmental Science & Technology|2010|237